GROUP ONE TRADING, L.P. - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 135 filers reported holding VIKING THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,838,993
-27.3%
527,461
+6.5%
0.02%
-23.1%
Q2 2023$8,031,974
-6.5%
495,495
-4.0%
0.03%
-16.1%
Q1 2023$8,590,601
+21.5%
515,952
-31.4%
0.03%
+93.8%
Q4 2022$7,067,963
+1658.2%
751,911
+409.4%
0.02%
+1500.0%
Q3 2022$402,000
+14.9%
147,616
+21.8%
0.00%0.0%
Q2 2022$350,000
-2.8%
121,158
+1.0%
0.00%
Q1 2022$360,000
-12.4%
119,944
+34.1%
0.00%
Q4 2021$411,000
-10.1%
89,416
+22.9%
0.00%
Q3 2021$457,000
+20.9%
72,765
+15.2%
0.00%
Q2 2021$378,000
-13.7%
63,166
-8.8%
0.00%
-100.0%
Q1 2021$438,000
-76.2%
69,273
-78.8%
0.00%
-66.7%
Q4 2020$1,843,000
+127.8%
327,397
+135.6%
0.00%0.0%
Q3 2020$809,000
-12.6%
138,934
+8.2%
0.00%
-25.0%
Q2 2020$926,000
+52.6%
128,391
-1.0%
0.00%
-20.0%
Q1 2020$607,000
+401.7%
129,714
+760.6%
0.01%
+400.0%
Q4 2019$121,000
-85.5%
15,073
-87.6%
0.00%
-85.7%
Q3 2019$835,000
+208.1%
121,434
+272.3%
0.01%
+250.0%
Q2 2019$271,000
-63.8%
32,614
-56.7%
0.00%
-75.0%
Q1 2019$748,000
-49.9%
75,284
-61.4%
0.01%
-38.5%
Q4 2018$1,494,000
-80.1%
195,272
-54.7%
0.01%
-78.0%
Q3 2018$7,517,000
+353.1%
431,513
+146.8%
0.06%
+321.4%
Q2 2018$1,659,000
+1206.3%
174,855
+503.8%
0.01%
+1300.0%
Q1 2018$127,00028,9590.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders